Perspectives and controversies in the prevention of infection in granulocytopenic patients.
D000380:Agranulocytosis / Q000150:complications*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000517:prevention & control*; D004780:Environment, Controlled; D006801:Humans; D007165:Immunosuppression Therapy; D009181:Mycoses / Q000517:prevention & control*; D009369:Neoplasms / Q000628:therapy; D010357:Patient Isolators
D000900:Anti-Bacterial Agents